Dr. Bruno Kaseler is CEO of Kaesler Nutrition, a worldwide active company with 130 million € turnover and 140 employees.

Kaesler Nutrition has production facilities for antioxidants, flavors, colorants, drinking water applications, vitamin formulation, blends and premixes in Cuxhaven (Germany), a research center in Bremerhaven (Germany), a joint venture to produce enzyme formulations in Wuhan (China), and a subsidiary for quality control and purchase in Shanghai.

In October 2014 Bruno Kaesler bought the Animal Nutrition Business of Lohmann Animal Health from Eli Lilly and founded Lohmann Animal Nutrition, since December 2016 the company trades under the name Kaesler Nutrition.

Previously he was Managing Director, Lohmann Animal Health and Chairman, Lohmann SE. He developed Lohmann Animal Health into a successful international company with market leadership positions in poultry vaccines and he developed business in pharmaceutical production, SPF egg production, human biotech CDMO (contract development and production under GMP) and feed additives.

Dr. Kaesler’s hobbies include triathlon, mountain trekking and he is an active Rotary member.